Suzuki, Ginga https://orcid.org/0000-0002-9854-3411
Iwanami, Yuji
Nakazawa, Masayoshi
Yoshioka, Shunta
Furuta, Masashi
Nakanishi, Masaru
Kanayama, Hiromi
Ishikawa, Kohei
Nishioka, Saria
Kobori, Toshimitsu
Masuyama, Yuka
Yamamoto, Saki
Shimanuki, Yui
Serizawa, Hibiki
Nakamichi, Yoshimi
Honda, Mitsuru
Washizawa, Naohiro
Okuni, Ikuko
Article History
Received: 1 October 2025
Accepted: 16 February 2026
First Online: 21 February 2026
Declarations
:
: The study protocol has been approved by the Ethics Committee of Toho University Faculty of Medicine (approval number: T2024-2411). Written informed consent will be obtained prior to enrollment. For patients who are conscious and capable of making decisions, consent will be obtained directly; for those who lack decision-making capacity, consent will instead be sought from family members or legally authorized representatives. When initial consent is obtained from a legally authorized representative (LAR), participants will be re-informed about the study and asked to provide written informed consent once they regain decision-making capacity. Participants will have the right to withdraw consent at any time without any impact on their clinical care. Participant information will be handled with strict confidentiality, and all data will be stored securely. The study findings will be disseminated through conference presentations and publications in peer-reviewed journals.
: All authors have read and approved the final manuscript and consent to its publication.
: The authors declare that they have no competing interests.